Evidence map›Paper›PMID 24651473›Full record

ArticlePloS one2014

B-cell-intrinsic hepatitis C virus expression leads to B-cell-lymphomagenesis and induction of NF-κB signalling.

Yuri Kasama, Takuo Mizukami, Hideki Kusunoki, Jan Peveling-Oberhag, Yasumasa Nishito, Makoto Ozawa, Michinori Kohara, Toshiaki Mizuochi, Kyoko Tsukiyama-Kohara

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02717949 (Oral Hepatitis C Treatment for Indolent Lymphoma), which is not on this map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02717949 phase4terminatednot on this mapstarted 2016, after this paper: background citation

Oral Hepatitis C Treatment for Indolent Lymphoma (OPTImaL) Study

TypeinterventionalSponsorUniversity of Texas Southwestern Medical CenterRan2016 to 2017Enrolled1ConditionsLiver DiseaseArmssofosbuvir/ledipasvir, sofosbuvir, Ribavirin
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Hepatitis C virus - associated B cell non-Hodgkin's lymphoma.World journal of gastroenterology · 2016
    Review
  5. Review
  6. Article
  7. Systemic lupus erythematosus and malignancies risk.Journal of cancer research and clinical oncology · 2016
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 2 countries.

Yuri KasamaDepartment of Experimental Phylaxiology, Faculty of Life Sciences, Kumamoto University, Kumamoto-shi, Kumamoto, Japan.
Takuo MizukamiDepartment of Research on Blood and Biological Products, National Institute of Infectious Diseases, Musashi-Murayama-shi, Tokyo, Japan.
Hideki KusunokiDepartment of Research on Blood and Biological Products, National Institute of Infectious Diseases, Musashi-Murayama-shi, Tokyo, Japan.
Jan Peveling-OberhagDepartment of Internal Medicine, Goethe-University Hospital, Frankfurt, Germany.
Yasumasa NishitoCenter for Microarray Analysis, Tokyo Metropolitan Institute of Medical Science, Kamikitazawa, Tokyo, Japan.
Makoto OzawaTransboundary Animal Diseases Center, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan; Laboratory of Animal Hygiene, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan.
Michinori KoharaDepartment of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Kamikitazawa, Tokyo, Japan.
Toshiaki MizuochiDepartment of Research on Blood and Biological Products, National Institute of Infectious Diseases, Musashi-Murayama-shi, Tokyo, Japan.
Kyoko Tsukiyama-KoharaTransboundary Animal Diseases Center, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan; Laboratory of Animal Hygiene, Joint Faculty of Veterinary Medicine, Kagoshima University, Kagoshima, Japan.
National Institute of Infectious Diseases · JPKagoshima University · JPTokyo Metropolitan Institute of Medical Science · JPGoethe University Frankfurt · DEKumamoto University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis C virus (HCV) infection leads to the development of hepatic diseases, as well as extrahepatic disorders such as B-cell non-Hodgkin's lymphoma (B-NHL). To reveal the molecular signalling pathways responsible for HCV-associated B-NHL development, we utilised transgenic (Tg) mice that express the full-length HCV genome specifically in B cells and develop non-Hodgkin type B-cell lymphomas (BCLs). The gene expression profiles in B cells from BCL-developing HCV-Tg mice, from BCL-non-developing HCV-Tg mice, and from BCL-non-developing HCV-negative mice were analysed by genome-wide microarray. In BCLs from HCV-Tg mice, the expression of various genes was modified, and for some genes, expression was influenced by the gender of the animals. Markedly modified genes such as Fos, C3, LTβR, A20, NF-κB and miR-26b in BCLs were further characterised using specific assays. We propose that activation of both canonical and alternative NF-κB signalling pathways and down-regulation of miR-26b contribute to the development of HCV-associated B-NHL.

Indexed as

Signal TransductionAnimalsB-LymphocytesCell NucleusFluorescent Antibody TechniqueGene Expression Regulation, NeoplasticHepacivirusHepatitis CLymphoma, B-CellMice, TransgenicMicroRNAsNeoplasm ProteinsNF-kappa BOligonucleotide Array Sequence AnalysisProtein TransportSoftwareMicroRNAsMirn26 microRNA, mouseNeoplasm ProteinsNF-kappa BTranscription Factor RelA

Identifiers

PMID24651473
PMCPMC3961254
OpenAlexW2053373046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.